Interestingly, in two orthotopic mouse models of HNSCC, the treatment with RT and anti-PD-1 mAb induced the upregulation of TIM-3 in CD8+ and CD4+ T cells, mainly in Tregs, mediating treatment resistance. Here, CD8A is linked to head and neck squamous cell carcinoma.